Supplier
Catholic Health Initiatives Colorado
Catholic Health Initiatives Colorado was paid $5.98M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99283, emergency room visit (moderate) — 40% of everything it billed.
33Billing provider infoCATHOLIC HEALTH INITIATIVES COLORADO
DURANGO, CO 81301
DURANGO, CO 81301
33aNPI1083611644assigned 06/28/2005
33bProvider typeInstitutional Pharmacy
28Total paid$5.98M
24GClaims143,275
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RICHERT, TADD controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,023 | $690K | |
| 2019 | 14,128 | $641K | |
| 2020 | 14,711 | $636K | |
| 2021 | 20,323 | $941K | |
| 2022 | 24,893 | $1.14M | |
| 2023 | 29,326 | $1.12M | |
| 2024incomplete | 22,871 | $807K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 40% | 16,569 | 15,440 | $2.39M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 6,915 | 6,419 | $1.13M |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.5% | 2,270 | 2,024 | $446K |
| 80053 | Comprehensive metabolic panel | 5.6% | 20,002 | 17,862 | $334K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.2% | 1,452 | 1,309 | $250K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.6% | 1,887 | 1,756 | $213K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.7% | 1,997 | 1,883 | $163K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.7% | 2,617 | 2,435 | $100K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 26,862 | 23,491 | $84K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.3% | 173 | 167 | $79K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.2% | 2,656 | 2,469 | $74K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 3,836 | 3,246 | $67K |
100 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 6,085 | $67K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 468 | $51K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,742 | $41K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 383 | $40K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 870 | $38K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 125 | $33K |
| 83605 | <1% | 740 | $27K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 251 | $23K |
| 0012A | <1% | 292 | $21K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,479 | $21K |
| 86140 | <1% | 1,489 | $18K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 434 | $16K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,717 | $14K |
| 0011A | <1% | 288 | $13K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 531 | $13K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 14 | $11K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,459 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 640 | $9K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,523 | $9K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 14 | $8K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 94 | $8K |
| 87081 | <1% | 349 | $8K | |
| 71045 | Radiologic examination, chest; single view | <1% | 463 | $8K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 218 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 594 | $7K |
| 84484 | <1% | 495 | $7K | |
| 86780 | <1% | 355 | $6K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $6K |
| 59025 | Fetal non-stress test | <1% | 45 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 123 | $6K |
| 87522 | Neg quan hep c or qual rna | <1% | 55 | $5K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 84 | $4K |
| 87340 | <1% | 354 | $4K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 226 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,793 | $4K |
| 86703 | <1% | 220 | $4K | |
| 73610 | <1% | 46 | $4K | |
| 86850 | <1% | 308 | $4K | |
| 86803 | <1% | 304 | $4K | |
| 83690 | <1% | 1,206 | $4K | |
| 87625 | <1% | 52 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 154 | $3K |
| 81001 | <1% | 1,163 | $3K | |
| 73630 | <1% | 40 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,891 | $2K |
| 80320 | <1% | 20 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 114 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 26 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 58 | $2K |
| 86901 | <1% | 342 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 13 | $2K |
| 86900 | <1% | 326 | $2K | |
| 87400 | <1% | 86 | $2K | |
| 80050 | General health panel | <1% | 116 | $2K |
| 83516 | <1% | 39 | $1K | |
| 82728 | <1% | 51 | $1K | |
| 85610 | <1% | 200 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 768 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 26 | $1K |
| Q3014 | Telehealth originating site facility fee | <1% | 74 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 315 | $1K |
| 81003 | <1% | 506 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 160 | $1K |
| 80061 | Lipid panel | <1% | 136 | $1K |
| 86762 | <1% | 90 | $1K | |
| 97597 | <1% | 40 | $1K | |
| 73562 | <1% | 13 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 414 | $870.49 |
| 82248 | <1% | 437 | $863.69 | |
| 87077 | <1% | 92 | $840.16 | |
| 84703 | <1% | 145 | $765.22 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 33 | $754.19 |
| 81025 | <1% | 123 | $708.44 | |
| 86359 | <1% | 13 | $644.33 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 288 | $565.29 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 333 | $510.33 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,009 | $497.40 |
| 94726 | <1% | 13 | $389.06 | |
| 87640 | <1% | 13 | $387.90 | |
| 86361 | <1% | 13 | $329.64 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 28 | $299.11 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 109 | $287.83 |
| 94729 | <1% | 13 | $226.19 | |
| 83540 | <1% | 12 | $162.93 | |
| 87641 | <1% | 13 | $142.93 | |
| 82565 | <1% | 29 | $118.86 | |
| 82105 | <1% | 13 | $112.36 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 29 | $96.63 |
| 82570 | <1% | 16 | $88.92 | |
| 85027 | <1% | 17 | $63.57 | |
| 84450 | <1% | 14 | $58.31 | |
| 84460 | <1% | 13 | $54.32 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 13 | $36.96 |
| 85652 | <1% | 16 | $26.93 | |
| A9270 | Non-covered item or service | <1% | 39 | $6.28 |
| 0753T | 0% | 215 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 11,771 | $0.00 |
| 82077 | 0% | 15 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 14 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICHERT, TADD (GROUP VP FINANCE)
Parent organizationCATHOLIC HEALTH INITIATIVES
| Provider | Location | Paid |
|---|---|---|
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $25.26M |
| Catholic Health Initiatives Colorado | Pueblo, CO | $23.66M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $8.91M |
| Catholic Health Initiatives Colorado | Canon City, CO | $8.35M |
| Catholic Health Iniatives Colorado | Westminster, CO | $7.55M |
| Catholic Health Initiatives Colorado | Canon City, CO | $6.39M |
| Longmont United Hospital | Longmont, CO | $5.25M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $4.40M |
| Commonspirit Kansas, INC. | Ulysses, KS | $2.77M |
| Commonspirit Kansas, INC. | Garden City, KS | $1.22M |
| Catholic Health Initiatives Colorado | Fort Morgan, CO | $1.17M |
| Catholic Health Iniatives Colorado | Frisco, CO | $691K |
| ST. Vincent Infirmary Medical Center | Sherwood, AR | $469K |
| Commonspirit Kansas, INC. | Dodge City, KS | $267K |
| Catholic Health Initiatives Colorado | Pueblo, CO | $153K |
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.